Don DeMaria
Research Subjects
Research Interests
Don DeMaria has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Doug R. Braun
Pharmaceutical Sciences Division, University of Wisconsin–Madison, Madison, WI 53705, USA
1 shared publication - Fan Zhang
Department of Pulmonary and Critical Care Medicine Zhongnan Hospital School of Pharmaceutical Sciences TaiKang Center for Life and Medical Sciences Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education) Wuhan University Wuhan PR China
1 shared publication - Scott R. Rajski
Pharmaceutical Sciences Division, University of Wisconsin–Madison, Madison, WI 53705, USA
1 shared publication - Timothy S. Bugni
School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA
1 shared publication
Latest Publications
- Open Access
- 12 December 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (12) , 698
Enhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium Enhygromyxa sp.
To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing actinobacterial secondary metabolites. This realization suggests the immense potential of myxobacteria as an intriguing source of secondary metabolites with unusual structural features and a wide array of biological activities. Marine-derived myxobacteria are especially attractive due to their unique biosynthetic gene clusters, although they are more difficult to handle than terrestrial myxobacteria. Here, we report the discovery of two new pyrazinone-type molecules, enhypyrazinones A and B, from a marine-derived myxobacterium Enhygromyxa sp. Their structures were elucidated by HRESIMS and comprehensive NMR data analyses. Compounds 1 and 2, which contain a rare trisubstituted-pyrazinone core, represent a unique class of molecules from Enhygromyxa sp.
- 12 December 2019
- Published by MDPI AG in Marine Drugs
- Vol. 17 (12) , 698
Open AccessEnhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium Enhygromyxa sp.
To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing actinobacterial secondary metabolites. This realization suggests the immense potential of myxobacteria as an intriguing source of secondary metabolites with unusual structural features and a wide array of biological activities. Marine-derived myxobacteria are especially attractive due to their unique biosynthetic gene clusters, although they are more difficult to handle than terrestrial myxobacteria. Here, we report the discovery of two new pyrazinone-type molecules, enhypyrazinones A and B, from a marine-derived myxobacterium Enhygromyxa sp. Their structures were elucidated by HRESIMS and comprehensive NMR data analyses. Compounds 1 and 2, which contain a rare trisubstituted-pyrazinone core, represent a unique class of molecules from Enhygromyxa sp.